FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL

Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma.

Related Keywords

Boston ,Massachusetts ,United States ,Dana Farber Cancer Institute ,Ashling Wahner ,Matthews Davids ,Eli Lilly ,Twitter ,Harvard Medical School ,Linkedin ,Clinical Research ,Center At Dana Farber Cancer Institute ,Facebook ,Live On Air ,Onclive On Air ,Apple Podcasts ,Google Podcasts ,Amazon Music ,Fda Approval Of Pirtobrutinib ,Patients With Previously Treated Chronic Lymphocytic Leukemia Small Lymphoma ,D ,Msc ,